Unknown

Dataset Information

0

Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.


ABSTRACT: A Japanese study reported that up to 16% of breast cancer samples harbor a sporadic mutation within the human Cav-1 gene, namely P132L. To date, however, no studies have examined the United States' population. Here, we developed a novel allele-specific real-time PCR assay to detect the Cav-1 P132L mutation in mammary tumor cells isolated by laser capture microdissection from formalin-fixed paraffin-embedded breast cancer samples. We report that the Cav-1 P132L mutation is present in approximately 19% of estrogen receptor alpha (ERalpha)-positive breast cancers but not in ERalpha-negative breast cancers. This is the first demonstration that the P132L mutation is exclusively associated with ERalpha-positive mammary tumors. We also identified six novel Cav-1 mutations associated with ERalpha-positive breast cancers (W128Stop, Y118H, S136R, I141T, Y148H, and Y148S). Thus, the overall incidence of Cav-1 mutations in ERalpha-positive breast cancers approaches 35% (greater than one-third). To mechanistically dissect the functional relationship between Cav-1 gene inactivation and ERalpha expression, we isolated primary mammary epithelial cells from wild-type and Cav-1-/- mice and cultured them in a three-dimensional system, allowing them to form mammary acinar-like structures. Under conditions of growth factor deprivation, Cav-1-deficient mammary acini displayed increased ERalpha levels and enhanced sensitivity toward estrogen-stimulated growth, with specific up-regulation of cyclin D1. Finally, we discuss the possibility that sporadic Cav-1 mutations may act as an initiating event in human breast cancer pathogenesis.

SUBMITTER: Li T 

PROVIDER: S-EPMC1606619 | biostudies-literature | 2006 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Li Tianhong T   Sotgia Federica F   Vuolo Magalis A MA   Li Maomi M   Yang Wan Cai WC   Pestell Richard G RG   Sparano Joseph A JA   Lisanti Michael P MP  

The American journal of pathology 20060601 6


A Japanese study reported that up to 16% of breast cancer samples harbor a sporadic mutation within the human Cav-1 gene, namely P132L. To date, however, no studies have examined the United States' population. Here, we developed a novel allele-specific real-time PCR assay to detect the Cav-1 P132L mutation in mammary tumor cells isolated by laser capture microdissection from formalin-fixed paraffin-embedded breast cancer samples. We report that the Cav-1 P132L mutation is present in approximatel  ...[more]

Similar Datasets

| S-EPMC3998833 | biostudies-literature
| S-EPMC10883292 | biostudies-literature
| S-EPMC555753 | biostudies-literature
| S-EPMC8492518 | biostudies-literature
| S-EPMC3244171 | biostudies-literature
| S-EPMC10088125 | biostudies-literature
| S-EPMC3742961 | biostudies-literature
| S-EPMC4561556 | biostudies-literature
| S-EPMC4348968 | biostudies-literature
| S-ECPF-GEOD-22035 | biostudies-other